 DUBLIN, Ireland and TREVOSE, Pa., Sept. 23, 2021 GLOBE NEWSWIRE -- Strongbridge Biopharma plc NASDAQ: SBBP the Company or Strongbridge today announced that the High Court of Ireland the Court has set the date of the final court hearing to sanction the proposed acquisition of Strongbridge by Xeris Pharmaceuticals, Inc. Xeris by means of scheme of arrangement the Scheme under Chapter 1 of Part 9 of the Irish Companies Act 2014 the Act. 